America’s Largest Mobile OEMs: Apple Inc. (AAPL) Overtakes LG for No. 2 Spot

Apple Inc. (NASDAQ:AAPL) fanboys would have you believe that the Cupertino-based tech giant is easily the world’s largest smartphone provider, and that when God cries, his tears are made of iPhones. As market share data tells us, however, this is simply not the case.

According to a new report by comScore MobiLens (originally reported by AppleInsider), Apple held approximately 17.8% of the mobile OEM (original equipment manufacturer) market at the end of October, second to only Samsung Electronics Co., Ltd.¬†(LON:BC94)‘s mammoth 26.3% share. In the period between July and October, Apple’s market share in this arena improved by 1.5 percentage points to place it above¬†LG Display Co Ltd. (NYSE:LPL), which currently holds 17.6% of the market.

Apple Inc. (NASDAQ:AAPL)

While the report doesn’t indicate the exact drivers behind this growth — the largest experienced by any member of the top five by a full eight-tenths of a percentage point — we can speculate that the iPhone 5 played a role. As we already discussed yesterday (see “Older iPhones Cutting Into iPhone 5 Sales“), Apple Inc. (NASDAQ:AAPL)’s iPhone 5 makes up a smaller percentage of its overall smartphone revenue, but this base is expected to grow by 25-30% YOY by the end of the quarter.

Coupled with the fact that Apple Inc. (NASDAQ:AAPL) now offers its “legacy” phones at lower-than-usual discounts, and we can now see why the tech giant’s market share may be improving. While it’s likely that margins will continue to be squeezed in the short term, investors can’t argue with growth, especially at the stock’s current valuation. For a longer look at Insider Monkey’s recent AAPL coverage, continue reading here.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!